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Reconstructive techniques using flaps or implants to preserve 
the enveloping skin, and even the nipple areolar complex, have 
undergone vast improvements in recent years. Secondary refine-
ments of the shape of reconstructed breasts have become rela-
tively routine as patients and plastic surgeons desire further im-
provements, and many plastic surgeons consider the technique 
of autologous fat grafting for this purpose [1]. Although the 
American Society of Plastic and Reconstructive Surgeons’ posi-
tion paper in 1987 stated that fat grafting would compromise 
breast cancer detection and should therefore be prohibited [2], 
Autologous Fat Graft in the Reconstructed Breast: 
Fat Absorption Rate and Safety based on 
Sonographic Identification
Hong Youl Kim, Bok Ki Jung, Dae Hyun Lew, Dong Won Lee
Department of Plastic and Reconstructive Surgery, Institute for Human Tissue Restoration, Severance Hospital, Yonsei University College of 
Medicine, Seoul, Korea
Background Autologous fat graft has become a useful technique for correction of acquired 
contour deformity in reconstructed breasts. However, there remains controversial regarding 
the efficacy and safety of the practice for reconstructive breast surgery.
Methods A retrospective review was performed on 102 patients who had secondary fat 
grafting after breast reconstruction. Fat harvest, refinement and injection were done by 
Coleman’s technique. All patients were followed up postoperatively within 1 month and after 
6 months including physical examination and ultrasonography. In 38 patients, the reabsorption 
rate was calculated by serial changes of thickness between skin and pectoral fascia in the 
ultrasonic finding. Locoregional recurrence rate was compared with control group of 449 
patients who had breast reconstruction without fat graft in the same time period.
Results Average 49.3 mL fat was injected into each breast. The most common location of fat 
graft was upper pole, followed by axilla, lower and medial breasts. During 28.7 months of 
average follow-up period, 2.9% of total patients had symptoms of palpable mass on fat graft 
side and ultrasonography identified fat necrosis and cyst formation in 17.6% of the patients. 
Calculated fat reabsorption rate was 32.9%. Locoregional recurrence was occurred in 1 patient 
(0.9%) and the rate was not different significantly with control group (2%).
Conclusions Although further studies are required to provide surgeons with definitive 
guidelines for the implementation of fat grafting, we propose autologous fat graft is an 
efficient and safe technique for secondary breast reconstruction.
Keywords Breast / Fat necrosis / Ultrasonography
Correspondence: Dong Won Lee 
Department of Plastic and 
Reconstructive Surgery, Yonsei 
University College of Medicine,





No potential conflict of interest relevant 
to this article was reported.
Received: 9 May 2014 • Revised: 23 Jun 2014 • Accepted: 6 Jul 2014
pISSN: 2234-6163 • eISSN: 2234-6171 • http://dx.doi.org/10.5999/aps.2014.41.6.740 • Arch Plast Surg 2014;41:740-747
Vol. 41 / No. 6 / November 2014
741
there is currently no evidence that fat grafting to breasts is less 
safe than any other form of breast surgery. Moreover, since the 
mid-2000s, several plastic surgeons reported good results using 
autologous fat grafting to correct contour deformities in the re-
constructed breasts [3,4].
However, controversy remains regarding the efficacy and safe-
ty of autologous fat grafts for reconstructive breast surgery. 
There are several potential drawbacks of autologous fat grafts in 
reconstructed breast. These include interference with the subse-
quent diagnosis of breast cancer by radiologic studies; unpre-
dictable fat reabsorption rates, which may affect the efficacy; 
and a possible increased risk of neoplasia [5]. Furthermore, it 
has been suggested that growth factors derived from adipocytes 
may stimulate the formation of breast cancer [6]. It is important 
to reach a consensus about these concerns to determine the 
most appropriate use of fat graft in patients with prior breast 
cancer surgery.
The aim of this study was to identify the long-term efficacy 
and safety of autologous fat graft after mastectomy and recon-
struction by implants or flaps in patients with breast cancer. We 
examined rate of such complications as fat necrosis and cyst for-
mation noted on follow-up ultrasounds, the graft reabsorption 
rate, and the rate of cancer recurrence.
METHODS
Patients
The study included 102 patients with a history of breast cancer 
who underwent autologous fat graft for secondary revision 
breast surgery between January 2005 and August 2013. Their 
mean age was 46.3 years (range, 22–63 years). The type of origi-
nal reconstruction surgery was transverse rectus abdominis 
myocutaneous free flap reconstruction (n = 15), latissimus dorsi 
(LD) myocutaneous island flap (n = 41), or implant reconstruc-
tion (n = 46). For 90 patients, the reconstruction was immedi-
ate, being performed in conjunction with the general surgery 
team, whereas for 12 patients, the reconstruction was delayed. 
Fat graft was performed on the left breast in 53 patients and on 
the right side in 49 patients. The type of cancer was ductal carci-
noma in situ (n = 42), stage I (n = 39), stage IIA (n = 13), stage 
IIB (n = 7), and stage IIIA (n = 1). The mean time interval be-
tween mastectomy and fat graft was 12.5 months (range, 3.2–
62.2 months). 
We estimated the data statistically with generalized estimating 
equations (GEE). Because a patient may have multiple fat graft-
ing sites, we analyzed the correlation between fat grafting sites 
and operation methods with GEE, not chi-square test which is 
used more generally. As a result of the estimation, we found that 
there was no statistic correlation (P = 0.815) between fat graft-
ing sites and operation methods.
Fat harvesting, refinement, and injection
The fat donor sites were the abdomen and flank for 91 patients 
and the thigh in 11 patients. Fat was harvested by Coleman’s 
technique [7]. First, a tumescent solution of 1,000 mL normal 
saline, 20 mL 2% lidocaine, and 1 mL 1:100,000 epinephrine 
was injected into the fat harvest area. We then waited for ap-
proximately 20 minutes to allow for dispersion of the tumescent 
solution. Using a two-hole Coleman harvesting cannula (Tulip 
Medical Products, San Diego, CA, USA) and a 50 mL syringe, 
fat harvesting was performed. The fat graft was collected with a 
10 mL Luer Lock syringe fitted directly on the cannula, and 
then transferred to a standard centrifuge. After centrifugation at 
3,000 rpm for 3 minutes, the supernatant oil was wicked off and 
the fluid at the dependent portion of the syringe was decanted. 
The fat graft was placed into syringes for transfer through Cole-
man cannulas into the soft-tissue deformities. Small aliquots of 
fat were injected through multiple passes and tissue planes to 
improve the likelihood of graft implantation, overcorrecting the 
defects according to the surgeon’s judgment.
Postoperative follow-up
Before fat grafting (T0), the breast was evaluated by physical ex-
amination, gross photography, and ultrasonography at our out-
patient clinic. We repeated these evaluations within 1 month af-
ter fat injection (T1). Between 1 month and 6 months (T2) after 
fat grafting, the breast was evaluated by physical examination 
alone. At 6 months after fat grafting (T3), we again evaluated the 
breast by physical examination, gross photography, and ultraso-
nography. The evaluations at T2 and T3 were used to assess the 
presence of complications.
Fat reabsorption rate
For 38 patients who underwent upper portion fat injection, fat 
reabsorption rate was calculated using ultrasonography mea-
surements of the depth of fat tissue from skin to pectoralis mus-
cle fascia. The fat thickness was measured at the middle points 
of the lines between the nipple (if the patient has no nipple, the 
maximal projection of breast mound substituted the point of 
nipple) and the points of the outer edge of the gland at the 
12-o’clock position (Fig. 1). The depth of fat tissue was mea-
sured at the same area at times T0, T1, and T3. The reabsorp-
tion rate was calculated using the following formula, with A, B, 
and C representing the measurements at T0, T1, and T3, respec-
tively: [1-(C-A)/(B-A)] × 100) (Fig. 2).
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Locoregional recurrence
After mastectomy, regular follow-up was performed with ultra-
sonography and physical examination by an oncologic surgeon 
to detect loco-regional recurrence in the fat injection group. 
Regular follow-up was performed in a similar manner in a group 
of control patients who were not injected autologous fat. Other 
methods, such as abdominal ultrasonography, whole body bone 
scan, and abdomino-pelvic and chest computed tomography, 
were used to detect distant metastasis.
RESULTS
During the initial injection, the average volume of injection was 
49.3 mL (range, 10–183 mL). Fat injection was performed only 
once for the majority of patients (n = 94). For the majority of pa-
tients, the location of injection was the upper pole of the breast, 
followed by axilla, lower pole and medial portion (Table 1).
Fat graft was repeated in 29 of the 102 patients (28.4%). Of 
these 29, 25 patients underwent fat graft a total of two times, 
and 4 patients underwent fat graft a total of three times. The 
mean volume of the additional injections was 37 mL (range, 
24–80 mL). At the initial procedure, the volume of fat injected 
in those patients who underwent repeat injections was slightly 
lower than the volume injected in the patients who did not have 
a repeat injection (42 mL vs. 50 mL).
Complications
Complications, including fat necrosis and cyst formation, de-
tected by ultrasonograpy of the fat injection site, occurred in 18 
of the 102 patients (17.6%) (Table 2, Fig. 3). No infection or 
implant rupture was noted. Details regarding each complication 
are provided in Table 2. The presence of a complication was as-
sociated with the volume of fat injected. The mean total volume 
of fat injected into the breasts was 67.5 mL for those patients 
who developed complications following the procedure, whereas 
The fat thickness was measured at the point as shown by the aster-
isks, namely, the middle points of the lines between the nipple and 
the points of the outer edge of the gland at 12-o’clock position.
Fig. 1. The point of measurement of the fat depth by 
ultrasonography 
Fig. 2. Measurement of fat reabsorption rate by ultrasonography 
(A) A: thickness before fat graft. (B) B: thickness within 1 month after fat graft. (C) C: thickness at more than 6 months after fat graft. The thick-
ness was measured from skin to pectoralis muscle fascia, C fat reabsorption rate was calculated by [1-(C-A)/(B-A)]×100.
A B C
Type of reconstruction Upper (%) Medial (%) Lower (%) Axilla (%)
Transverse rectus abdominis myocutaneous 57.1 4.8 28.6 9.5
Latissimus dorsi 60.7 16.1 10.7 12.5
Implant 67.7 7.7 7.7 17.0
Total 63.4 10.6 12.0 14.1
There was no significant difference between fat injection site and type of reconstruction (P=0.815).
Table 1. Location of fat graft
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the fat volume was 45.2 mL for those without complications. Of 
the 18 patients with complications, 10 had fat necrosis, and 8 
had cystic lesions. Among them, only three patients complained 
of a palpable mass, which led to a biopsy; pathologic examina-
tion confirmed as fat necrosis. All cases complained palpable 
mass or not was conservatively managed with no other proce-
dure like surgical excision or drainage. But regular follow up was 
done.
Fat reabsorption rate and loco-regional recurrence
For the 38 patients in whom the fat reabsorption rate was calcu-
lated, the mean rate was 32.9% (range, 25%–52%) (Fig. 4). At 
before and after 6 months of fat injection, the gross photograph 
were shown in patient underwent implant reconstruction and 
Patient  Complication Age (yr) Reconstruction method Adjuvant therapy Number of graft Graft volume (mL)a)
1 Cystic lesion 43 Implant None 1 49
2 Cystic lesion 52 TRAM CTx 2 101
3 Fat necrosis 34 LD CTx 1 45
4 Cystic lesion 43 LD None 1 82
5 Fat necrosis 52 TRAM RTx 1 20
6 Fat necrosis 47 Implant CTx 1 20
7 Cystic lesion 51 TRAM None 1 93
8 Cystic lesion 38 LD CTx, RTx 2 68
9 Fat necrosis 52 Implant None 1 66
10 Fat necrosis 60 LD None 1 150
11 Cystic lesion 35 LD None 1 55
12 Fat necrosis 43 LD None 1 60
13 Cystic lesion 36 LD None 1 55
14 Fat necrosis 38 LD CTx 2 114
15 Fat necrosis 57 LD None 1 183
16 Cystic lesion 37 Implant None 2 205
17 Fat necrosis 58 Implant CTx 1 40
18 Fat necrosis 65 LD None 1 80
TRAM, transverse rectus abdominis myocutaneous; CTx, chemotherapy; LD, latissimus dorsi; RTx, radiotherapy.
a)In multiple fat graft group, the graft volume was calculated together.
Table 2. Complications following fat graft
(A) A 60-year-old woman, who initially un-
derwent latissimus dorsi myocutaneous 
flap reconstruction, was noted to have fat 
necrosis at 38 months after fat graft with 
150 mL in the left breast. (B) A 43-year-old 
woman, who initially underwent implant 
reconstruction, was noted to have a cyst 
13 months after fat graft with 49 mL in the 
left breast.
Fig. 3. Complication after the fat graft
A B
Before (A)
Within 1 mo (B)
After 6 mo (C)
Measurements of 38 patients who underwent upper pole fat injec-
tion from skin to pectoralis muscle fascia.
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LD myocutaneous flap reconstruction (Figs. 5, 6).
Loco-regional cancer recurrence was noted in 1 patient (0.9%) 
in the fat injection group. In a control group who did not under-
go fat graft, 9 of 449 patients (2.0%) were noted to have a recur-
rence in the same duration of follow-up. There was no signifi-
cant difference between fat graft group and control group.
DISCUSSION
Contour deformity and irregularity of the reconstructed breast 
can be a challenging problem. As the various methods of prima-
ry breast reconstruction have improved, expectations of patients 
and surgeons for a natural appearing, aesthetically appealing, 
and well-contoured final result have been raised. The main goal 
of breast reconstruction is to produce a natural appearing and 
symmetric mound of breast. However, in the immediate or later 
postoperative period, the contour of the reconstructed breast 
may become unsatisfactory, and further correction of the breast 
shape and contour at the time of other secondary procedures, 
such as nipple reconstruction, is not uncommon [1].
In our study, fat graft was performed in all quadrants of the 
breast, as well as the axilla. The most frequent fat graft area was 
the upper portion regardless of the reconstruction procedure. 
For LD myocutaneous flap reconstruction, a lack of volume oc-
(A, B) Preoperative views of a 34-year-old patient with left breast traction rippling caused by a textured implant and scant upper pole volume. (C, 
D) Results at 9 months postoperatively, following a single injection of 40 mL of autologous fat to the left breast upper pole. 
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(A, B) Preoperative views of a 42-year-old patient with an immediate right breast latissimus dorsi myocutaneous island transposition flap. (C, D) 
Results at 6 months postoperatively, following a single injection of 60 mL autologous fat to the right upper pole. 





curred in many of our cases. When constructing a breast mound 
with a small volume, a relative lack of upper quadrant fullness is 
not unexpected. For implant reconstruction, it is difficult to ob-
tain a natural breast shape with a round implant, although use of 
an anatomically-shaped implant improves the appearance. 
Those cases could be indications for secondary refinement with 
fat graft.
The safety of microfat graft is evident in our series, as indicated 
by our low complication rate of 17.6%, which was limited to 
only minor complications. This rate is compatible with, al-
though slightly higher than, rates reported in the literature. In 
2005, Spear et al. [3] reported an 8.5% complication rate for the 
correction of contour deformities in 37 patients, and in 2011, 
Losken et al. [1] reported an 11% complication rate in 107 pa-
tients. One potential reason for our higher rate was our use of a 
higher fat graft volume. Minimizing the volume grafted with 
each pass of the cannula will maximize the surface area of con-
tact between the grafted fat and the recipient tissue. The prox-
imity of the newly grafted fat to a blood supply encourages sur-
vival and minimizes the potential for fat necrosis and later calci-
fication. Thus, it is not surprising that with a larger volume 
grafted, there was less surface contact between the grafted fat 
and the recipient tissue. The larger mean graft volume in our 
group with complications compared to those without complica-
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tions (67.5 mL vs. 45.2 mL) further illustrates the importance 
of graft volume. Another potential reason for the disc between 
our complication rate and those of previous studies was our use 
of a larger syringe with a large-caliber cannula for fat harvesting. 
Coleman and Saboeiro [7] recommended the use of a 10 mL 
syringe for fat harvesting to reduce the pressure generated dur-
ing the harvesting procedure and thereby potentially preserve 
the fat parcels [8]. We used a 50 mL syringe with a 3 mm caliber 
cannula to lead high negative pressure and to derive large fat 
parcels, which may have damaged the fat parcels and negatively 
influenced fat graft outcomes.
The fat reabsorption rate in this study was 32.9% (range, 25%–
52%). Clinically, volume loss between 40% and 60% has been 
reported after fat grafting, which usually occurs after 4 to 6 
months [9,10]. Although over-correction is performed by some 
surgeons, the need for re-grafting is often required and should 
be discussed with the patient initially. In our study, 28.4% of pa-
tients underwent more than one fat grafting procedure to 
achieve the optimal cosmetic result. In Delay’s [9] review of 200 
breast reconstructions, 22% underwent multiple fat grafts. Mis-
sana et al. [4] demonstrated a somewhat lower repeat injection 
rate of 15%. There are many methods for fat refinement, includ-
ing filtration, cotton gauze rolling, and centrifugation. Centrifu-
gation is the most commonly used method, and we centrifuged 
the harvested material at 3,000 rpm for 3 minutes, as this al-
lowed us to obtain a higher adipocyte concentration. Fisher et 
al. [11] found that among the fat refinement techniques, the 
cotton rolling method produced the highest stromal vascular 
fraction cell count; he recommended using this method when 
the volume of the graft was small. However, this method be-
comes more cumbersome for larger volume injections. The 
LipiVage System like Harvest-jet is also relatively easy to use and 
has been shown to yield a sufficient number of viable adipo-
cytes [12].
In 1987, the American Society of Plastic Surgeons prohibited 
the use of autologous fat grafting to the female breast because of 
concerns that it would interfere with subsequent cancer screen-
ing and that adipocytes may have tumor-promoting effects [4]. 
However, in terms of cancer screening, Pierrefeu-Lagrange et al. 
[13] reported the use of multimodal radiographic imaging in 30 
patients who underwent fat graft to the reconstructed breast, 
and it was felt that fat grafting did not interfere with oncologic 
surveillance in these patients. In our current study, the cancer 
locoregional recurrence rate was 0.9%; that is, it is proposed that 
no tumors recurred due to fat graft compared with control 
group recurrence (2.0%). Our cancer recurrence rate after fat 
grafting was significant lower than the rates reported by other 
studies. Rigotti et al. [14] reported the overall incidence of lo-
coregional or distant recurrence to be 5.9% after a 5-year follow-
up period. Previous studies have explored the potential tumori-
genic effects of fat cells. Ando and Catalano [15] reported that 
leptin is a cytokine-like protein secreted from adipocytes that 
plays a role in cell proliferation and neovascularization in malig-
nant and nonmalignant human cellular lines. Pearl et al. [6] sug-
gested that transference of adipose tissue and adipose-derived 
stem cells to an environment that has been in the locale of previ-
ous malignant change may constitute an unacceptable risk. Fur-
ther studies are necessary to more fully define the roles of adipo-
cytes, preadipocytes, and adipose-derived stem cell in tumori-
genesis, recurrence, and metastasis. 
One of our patients who showed locoregional recurrence orig-
inally had a history of partial mastectomy and axillary lymph 
node dissection under diagnosis of invasive ductal carcinoma, 
and 20 years later, recognized a mass-like lesion on the same 
breast which led her to receive total mastectomy under the same 
pathologic diagnosis. The patient underwent an implant-based 
breast mound reconstruction afterwards, and a nipple-areolar 
complex reconstruction surgery followed 9 months later togeth-
er with 40 mL of fat graft on depressed upper pole area. Twenty 
three months from the fat grafting procedure, a regular follow-
up whole body bone scan revealed increased uptake in the ster-
num suspicious of bone metastasis. A subsequent positron 
emission tomography-computed tomography scan further con-
firmed multiple sites of mestastasis in the sternum, left scapula, 
vertebral bodies, left pubic bone, and possible lung metastasis in 
the left lung base. The patient currently is under chemotherapy 
showing stable state of the disease, and additional chemothera-
py will be provided.
Although our results are encouraging, we recognize that this 
study has limitations. To provide definitive guidance to sur-
geons undertaking fat graft for breast reconstruction deformi-
ties, larger prospective studies are required. In particular, investi-
gations to determine the optimal volume of fat graft and the 
number of grafts to use would be of value. We measured the 
thickness by ultrasonography in determining the fat reabsorp-
tion rate, but several technologies, including 3-dimensional 
cameras, can be used to create three-dimensional images of the 
breast, which permit accurate evaluation of size, volume, and 
contour [16].
In this study of fat graft as a tool for acquired contour deformi-
ties of the reconstructed breast, we have demonstrated efficient 
outcomes and acceptable complication rate. It suggests that fat 
graft represents a promising intervention for the management of 
a common and distressing problem for patients who have un-
dergone postmastectomy breast reconstruction. However, sev-
eral issues, such as cancer recurrence, postoperative surveillance, 
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fat reabsorption rate, and the role of stromal vascular fraction 
cells, should continue to be explored to maximize the safety and 
outcomes of autologous fat grafting to the breast.
REFERENCES
1. Losken A, Pinell XA, Sikoro K, et al. Autologous fat grafting 
in secondary breast reconstruction. Ann Plast Surg 2011;66: 
518-22.
2. Report on autologous fat transplantation. ASPRS Ad-Hoc 
Committee on New Procedures, September 30, 1987. Plast 
Surg Nurs 1987;7:140-1.
3. Spear SL, Wilson HB, Lockwood MD. Fat injection to cor-
rect contour deformities in the reconstructed breast. Plast 
Reconstr Surg 2005;116:1300-5.
4. Missana MC, Laurent I, Barreau L, et al. Autologous fat 
transfer in reconstructive breast surgery: indications, tech-
nique and results. Eur J Surg Oncol 2007;33:685-90.
5. Gutowski KA; ASPS Fat Graft Task Force. Current applica-
tions and safety of autologous fat grafts: a report of the ASPS 
fat graft task force. Plast Reconstr Surg 2009;124:272-80.
6. Pearl RA, Leedham SJ, Pacifico MD. The safety of autolo-
gous fat transfer in breast cancer: lessons from stem cell biol-
ogy. J Plast Reconstr Aesthet Surg 2012;65:283-8.
7. Coleman SR, Saboeiro AP. Fat grafting to the breast revisit-
ed: safety and efficacy. Plast Reconstr Surg 2007;119:775-
85.
8. Toledo LS. Syringe liposculpture. Clin Plast Surg 1996;23: 
683-93.
9. Delay E. Lipomodeling of the reconstructed breast. In: Spear 
SL, editor. Surgery of the breast: principles and art. Philadel-
phia: Lippincott Williams & Wilkins; 2006. p.912-33.
10. Horl HW, Feller AM, Biemer E. Technique for liposuction 
fat reimplantation and long-term volume evaluation by mag-
netic resonance imaging. Ann Plast Surg 1991;26:248-58.
11. Fisher C, Grahovac TL, Schafer ME, et al. Comparison of 
harvest and processing techniques for fat grafting and adipose 
stem cell isolation. Plast Reconstr Surg 2013;132:351-61.
12. Ferguson RE, Cui X, Fink BF, et al. The viability of autolo-
gous fat grafts harvested with the LipiVage system: a com-
parative study. Ann Plast Surg 2008;60:594-7.
13. Pierrefeu-Lagrange AC, Delay E, Guerin N, et al. Radiologi-
cal evaluation of breasts reconstructed with lipomodeling. 
Ann Chir Plast Esthet 2006;51:18-28.
14. Rigotti G, Marchi A, Galie M, et al. Clinical treatment of ra-
diotherapy tissue damage by lipoaspirate transplant: a heal-
ing process mediated by adipose-derived adult stem cells. 
Plast Reconstr Surg 2007;119:1409-22.
15. Ando S, Catalano S. The multifactorial role of leptin in driv-
ing the breast cancer microenvironment. Nat Rev Endocri-
nol 2012;8:263-75.
16. Choi M, Small K, Levovitz C, et al. The volumetric analysis 
of fat graft survival in breast reconstruction. Plast Reconstr 
Surg 2013;131:185-91.
